Novel Sunifiram-carbamate hybrids as potential dual acetylcholinesterase inhibitor and NMDAR co-agonist: simulation-guided analogue design and pharmacological screening.
AChE inhibitors
N-acylbenzotriazole
NMDA receptor
Nootropic
Sunifiram
piperazine
Journal
Journal of enzyme inhibition and medicinal chemistry
ISSN: 1475-6374
Titre abrégé: J Enzyme Inhib Med Chem
Pays: England
ID NLM: 101150203
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
entrez:
29
4
2022
pubmed:
30
4
2022
medline:
3
5
2022
Statut:
ppublish
Résumé
An efficient method for synthesising NMDAR co-agonist Sunifiram (DM235), in addition to Sunifram-carbamate and anthranilamide hybrids, has been developed in high yields
Identifiants
pubmed: 35484855
doi: 10.1080/14756366.2022.2068147
pmc: PMC9067966
doi:
Substances chimiques
Carbamates
0
Cholinesterase Inhibitors
0
Nootropic Agents
0
Piperazines
0
Receptors, N-Methyl-D-Aspartate
0
DM 235
66924E735K
Donepezil
8SSC91326P
Acetylcholinesterase
EC 3.1.1.7
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1241-1256Références
J Enzyme Inhib Med Chem. 2016;31(2):187-94
pubmed: 25831025
Curr Pharm Biotechnol. 2016;17(14):1231-1245
pubmed: 27804852
Bio Protoc. 2013;3(24):
pubmed: 27390758
J Gen Physiol. 2015 Jun;145(6):513-27
pubmed: 25964432
J Cheminform. 2012 Aug 13;4(1):17
pubmed: 22889332
Neuropsychopharmacology. 2005 Mar;30(3):633-9
pubmed: 15647751
Expert Opin Investig Drugs. 2007 Jan;16(1):59-72
pubmed: 17155854
Acta Histochem. 2018 Apr;120(3):159-167
pubmed: 29496266
Methods Mol Biol. 2015;1263:243-50
pubmed: 25618350
Eur J Pharm Sci. 2002 Dec;17(4-5):253-63
pubmed: 12453615
J Med Chem. 2000 Nov 16;43(23):4499-507
pubmed: 11087574
Neural Plast. 2017;2017:2875904
pubmed: 28163934
Cancer Res. 2013 Feb 15;73(4):1328-39
pubmed: 23222296
Trends Neurosci. 1999 Jun;22(6):273-80
pubmed: 10354606
Sci Rep. 2018 Oct 8;8(1):14921
pubmed: 30297729
J Physiol. 2004 Jun 1;557(Pt 2):489-500
pubmed: 15064326
Pharmacol Rev. 1997 Dec;49(4):403-49
pubmed: 9443165
Biophys Rev. 2017 Apr;9(2):91-102
pubmed: 28510083
Arch Gen Psychiatry. 1995 Dec;52(12):998-1007
pubmed: 7492260
Biomed Pharmacother. 2014 May;68(4):493-6
pubmed: 24751001
Psychopharmacology (Berl). 2005 Dec;183(3):265-74
pubmed: 16220331
Lancet Psychiatry. 2020 Feb;7(2):191-207
pubmed: 31732482
J Med Chem. 2008 Jul 24;51(14):4200-12
pubmed: 18570368
Expert Opin Investig Drugs. 2014 Feb;23(2):243-54
pubmed: 24251380
Neuropharmacology. 2001 Jul;41(1):88-96
pubmed: 11445189
Neuroscience. 2006 Dec;143(3):671-8
pubmed: 17000053
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
pubmed: 11259830
CNS Drug Rev. 2006 Spring;12(1):39-52
pubmed: 16834757
Expert Rev Neurother. 2012 Nov;12(11):1351-65
pubmed: 23234396
J Med Chem. 2006 Aug 24;49(17):5051-8
pubmed: 16913695
J Med Chem. 2017 Nov 22;60(22):9097-9113
pubmed: 28609624
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
Biochem Pharmacol. 1961 Jul;7:88-95
pubmed: 13726518
Neurobiol Dis. 2004 Feb;15(1):80-92
pubmed: 14751773
J Clin Neurosci. 2007 Oct;14(10):919-27
pubmed: 17659875
Hippocampus. 2013 Oct;23(10):942-51
pubmed: 23733502
Curr Neuropharmacol. 2016;14(1):101-15
pubmed: 26813123
Iran J Pharm Res. 2015 Summer;14(3):949-54
pubmed: 26330885
Neuropharmacology. 2021 Jun 1;190:108352
pubmed: 33035532
Expert Opin Ther Pat. 2012 Nov;22(11):1337-52
pubmed: 23009122
Brain Res. 1998 Jun 8;795(1-2):215-20
pubmed: 9622635
Mol Med Rep. 2019 Aug;20(2):1479-1487
pubmed: 31257471
J Org Chem. 2011 Jun 17;76(12):4884-93
pubmed: 21452874
Neuropharmacology. 2013 Jan;64:13-26
pubmed: 22796429
Biochemistry. 2002 Mar 19;41(11):3555-64
pubmed: 11888271
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jun 8;92:387-404
pubmed: 30738126
Bioorg Chem. 2021 Sep;114:105100
pubmed: 34246972
NeuroRx. 2005 Oct;2(4):541-53
pubmed: 16489364
J Pharmacopuncture. 2019 Dec;22(4):231-238
pubmed: 31970020
Curr Opin Investig Drugs. 2006 Jul;7(7):608-13
pubmed: 16869112